<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 4, 2000
AMERICAN BIO MEDICA CORPORATION
------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
------------------------------- ------------------------ ----------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
----------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
<PAGE> 2
ITEM 5. OTHER EVENTS
On October 4, 2000, American Bio Medica Corporation, A New York
corporation, announced the departure of John F. Murray as chief financial
officer and treasurer and the appointment of Keith E, Palmer as American Bio
Medica Corporation's new chief financial officer, treasurer and vice president
of finance. A copy of American Bio Medica Corporation's press release announcing
this appointment is attached as and incorporated by reference herein.
2
<PAGE> 3
ITEM 7. EXHIBITS
(c) Exhibits
99.1 American Bio Medica Corporation press release dated 10-4-00
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION
(Registrant)
Dated: October 4, 2000 By: /s/ Stan Cipkowski
--------------------------------
Stan Cipkowski,
President and Principal
Executive Officer
4
